Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to 0.15%.

  • Arcutis Biotherapeutics' Return on Capital Employed rose 5300.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 5300.0%. This contributed to the annual value of 0.49% for FY2024, which is 2100.0% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Return on Capital Employed of 0.15% as of Q3 2025, which was up 5300.0% from 0.35% recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Return on Capital Employed high stood at 0.15% for Q3 2025, and its period low was 1.01% during Q2 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' median Return on Capital Employed value was 0.67% (recorded in 2022), while the average stood at 0.64%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -2100bps in 2023, then soared by 5700bps in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Return on Capital Employed (Quarter) stood at 0.57% in 2021, then decreased by -21bps to 0.68% in 2022, then tumbled by -30bps to 0.89% in 2023, then surged by 54bps to 0.41% in 2024, then skyrocketed by 65bps to 0.15% in 2025.
  • Its Return on Capital Employed was 0.15% in Q3 2025, compared to 0.35% in Q2 2025 and 0.48% in Q1 2025.